Introduction to Pancragen 20mg
Pancragen is a synthetic peptide bioregulator composed of short amino acid sequences associated with pancreatic cellular structures. It is studied in laboratory settings for its role in regulating gene expression and cellular signaling related to endocrine and exocrine pancreatic functions. The 20mg dosage format is standardized for reproducibility in experimental models.
Key Research Areas
Preclinical studies have investigated Pancragen for its potential roles in:
Pancreatic Tissue Modeling: Studying cellular regeneration, function, and structural maintenance in ex vivo and in vivo pancreas models.
Metabolic Regulation Research: Assessing peptide interactions with pathways involved in carbohydrate metabolism and pancreatic hormone signaling.
Endocrine System Studies: Exploring gene expression changes related to islet cell function in research organisms.
Oxidative Stress & Inflammation Models: Evaluating effects on pancreatic tissue under induced stress or toxic conditions.
For Research Use Only – Not for Human or Veterinary Use
Pancragen 20mg is not approved by the FDA for therapeutic or diagnostic purposes. It is intended solely for use in non-clinical laboratory research.
Certificate of Analysis
| Property | Description |
|---|---|
| Chemical Sequence | Ala-Glu-Asp-Leu |
| CAS | 158152-06-2 |
| Molecular Formula | C17H29N5O6 |
| Molecular Weight | Approximately 403.44 g/mol |
| Appearance | White Lyophilized Powder |
Research Use Only:
Pancragen 20mg is intended strictly for in vitro testing and laboratory experimentation. It is not intended for human or animal medical use. It is not a drug, food, or cosmetic and should not be misbranded, misused, or mislabeled as such.
